Transurethral balloon laser thermotherapy (TUBAL-T) is a new technique using Nd: YAG laser for benign prostatic hyperplasia (BPH), which can be performed under local anesthesia on an outpatient basis. In this method, laser irradiation is performed through 360° with a laser balloon catheter that is placed transurethrally in the prostatic urethra. Theoretically, the prostatic tissue is sufficiently coagulated and necrotised, while the urethral mucosa is preserved cooling with the circulating water in the laser balloon catheter.
From December 1993, we treated 20 cases with symptomatic BPH by TUBAL-T using PROSTALASE
TM (SLT Japan Co. Tokyo). We employed 50 to 60 watts laser output powers for 60 minutes. The clinical efficacy of the treatment was evaluated subjectively by AUA symptom score, objectively by urodynamics and imaging studies. At 3 months after the treatment, AUA symptom score, prostatic volume and post-voiding residual significantly decreased in all 15 evaluable cases, although uroflowmetric parameters showed no change. One the other hand, 3-year-followup study demonstrated that only 6 patients had satisfaction on urination without any supplementary treatment; 3 patients received transurethral resection of the prostate, 5 were treated with α
1-blocker and 1 dropped out.
In 4 cases, a clear prostatic cavity, which was connected to the urethra beside the vermontanum, was detected by imaging and ednoscopic studies. Concerning adverse events, massive haematuria, incontinence, stricture, retrograde ejaculation, impotence or rectal injury was not observed in any patients.
We conclude that TUBAL-T is applicable to high risk patiets without anesthesia, but needs some reform to improve the outcomes.
View full abstract